Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of two antibiotic combinations for treatment-resistant ulcerative colitis
MOH_2019-07-01_007237Phase 2Completed
- Sponsor
- דר' דרור וינר
- Start
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of amoxicillin, doxycycline and metronidazole in autoimmune colitis (2 arms), sponsored by דר' דרור וינר. Started May 2019; status: completed.
02
Drugs
amoxicillindoxycyclinemetronidazole
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on MOH_2019-07-01_007237.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2019-07-01_007237.